Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells.
Niklas Feldhahn, Florian Klein, Jana L Mooster, Paul Hadweh, Mieke Sprangers, Maria Wartenberg, Mohamed M Bekhite, Wolf-Karsten Hofmann, Sebastian Herzog, Hassan Jumaa, Janet D Rowley, Markus Müschen
Index: J. Exp. Med. 201 , 1837-52, (2005)
Full Text: HTML
Abstract
Pre-B cells undergo apoptosis unless they are rescued by pre-B cell receptor-dependent survival signals. We previously showed that the BCR-ABL1 kinase that is expressed in pre-B lymphoblastic leukemia bypasses selection for pre-B cell receptor-dependent survival signals. Investigating possible interference of BCR-ABL1 with pre-B cell receptor signaling, we found that neither SYK nor SLP65 can be phosphorylated in response to pre-B cell receptor engagement. Instead, Bruton's tyrosine kinase (BTK) is constitutively phosphorylated by BCR-ABL1. Activated BTK is essential for survival signals that otherwise would arise from the pre-B cell receptor, including activation of PLCgamma1, autonomous Ca2+ signaling, STAT5-phosphorylation, and up-regulation of BCLX(L). Inhibition of BTK activity specifically induces apoptosis in BCR-ABL1+ leukemia cells to a similar extent as inhibition of BCR-ABL1 kinase activity itself. However, BCR-ABL1 cannot directly bind to full-length BTK. Instead, BCR-ABL1 induces the expression of a truncated splice variant of BTK that acts as a linker between the two kinases. As opposed to full-length BTK, truncated BTK lacks kinase activity yet can bind to BCR-ABL1 through its SRC-homology domain 3. Acting as a linker, truncated BTK enables BCR-ABL1-dependent activation of full-length BTK, which initiates downstream survival signals and mimics a constitutively active pre-B cell receptor.
Related Compounds
Related Articles:
2015-03-01
[EMBO Mol. Med. 7(3) , 240-58, (2015)]
Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells.
2010-01-01
[Mol. Cancer 9 , 267, (2010)]
2009-04-13
[J. Exp. Med. 206(4) , 937-52, (2009)]
2013-01-01
[PLoS ONE 8 , e77615, (2013)]
2006-01-01
[J. Inflamm. (Lond.) 3 , 8, (2006)]